Ryan Madson threw off a mound yesterday for the first time since his comeback from Tommy John surgery was shut down on February 1 when he experienced elbow soreness.
Madson threw 20 pitches and afterward told Kevin Baxter of the Los Angeles Times that “it was just nice and easy, just to get back up on the hill.”
However, those 20 pitches were all fastballs and Madson was throwing at less than full effort, so he’s all but guaranteed to begin the season on the disabled list and the Angels figure to go with Ernesto Frieri as their Opening Day closer.
The Brewers’ rebuild continues, as the club announced on Twitter the trade of outfielder Khris Davis to the Athletics in exchange for catcher Jacob Nottingham and pitcher Bubba Derby. MLB.com’s Jane Lee reports that the A’s have designated pitcher Sean Nolin for assignment to create room on the 40-man roster for Davis.
More on this trade shortly.
Ken Rosenthal of FOX Sports reports that the Yankees and closer Aroldis Chapman have avoided arbitration, settling on an $11.325 million salary for the 2016 season. It is the lefty’s third and final year of arbitration eligibility.
Chapman had filed for $13 million while the Yankees countered at $9 million, so he gets slightly more than the midpoint between the two submitted figures.
With the Reds this past season, Chapman posted a 1.63 ERA with 33 saves and a 116/33 K/BB ratio over 66 1/3 innings. The Reds have opted to rebuild, so they traded him to the Yankees this offseason in exchange for four minor leaguers. Chapman, who turns 28 at the end of February, will make for a fearsome 1-2-3 punch in the back of the Yankees’ bullpen along with Andrew Miller and Dellin Betances.
Paul Hoynes of the Cleveland Plain Dealer reports that right-hander Tommy Hunter has agreed to a one-year, $2 million contract with the Indians. It’s a major-league deal, so Hunter gets a spot on the 40-man roster and will be in the Opening Day bullpen if he’s fully recovered from core muscle surgery.
Hunter split last season between the Orioles and Cubs, totaling 60 innings with a 4.18 ERA and 47/14 K/BB ratio. He had a sub-3.00 ERA in both 2013 and 2014, and has generally been a setup-caliber reliever since shifting to the bullpen full time.
He has good control and a mid-90s fastball, but Hunter has never missed many bats despite the big-time velocity and often struggles to keep the ball in the ballpark. He’ll likely fill a middle relief role in Cleveland initially.
You knew someone would be dumb enough to do this eventually, you just didn’t know who. Now we do: MLB just announced that reliever Jenrry Mejia has been permanently suspended after testing positive for Boldenone. That was his third positive test and under the Joint Drug Agreement that means his career is more or less over.
Mejia’s three strikes came in pretty rapid succession. On April 11, 2015 it was announced that Mejía had been suspended for 80 games after testing positive for use of stanozolol. On July 28, 2015 it was announced that Mejia had failed a test for Stanozolol again and Boldenone to boot, giving him a 162-game suspension, which he’d still be serving at the beggining of the season. Now this third test.
Mejia has played five seasons in the big. He started with so much promise, looking like a great prospect coming up. His performance only matched the promise in fits and starts, however, resulting in a 9-14 record with a 3.68 ERA and a K/BB ratio of 162/76 in 183.1 innings, all with the Mets.
Per the rules of the Joint Drug Agreement, Mejia can apply for reinstatement after being banned for two years. But it would obviously require him to spend two years doing a lot of smart things he hasn’t been doing in the past year. And it would also represent a near-unprecedented comeback. It could happen, I suppose, but it’s a far safer bet that his career is over.